High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML).

These results indicate a higher chance of survival for patients with low iASPP expression, which is independent of the ELN risk group (high statistical significance in low and intermediate risk, near significance in high risk cohorts with regard to OS and EFS, compare Fig. 3H (median OS and EFS rates are provided in Fig. 3I ; 1- and 2-year OS rates are listed in Table 1 ).

also in 151 other papers